|Change:||-$2.38 ( -0.93% )||52Wk High:||$255.47|
C. R. Bard, Inc. (Bard) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells a range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard has four product group categories: vascular, urology, oncology and surgical specialties. On January 11, 2008, Bard acquired LifeStent family of stents from Edwards Lifesciences Corporation. On June 5, 2008, the Company acquired Specialized Health Products International, Inc.
|S&P 500 Movers: RHI, WYNN||01/27/2017|
|Earnings Scheduled For January 26, 2017||01/26/2017|
|Analysts' Actions -- AIG, Fox, Lululemon, AT&T and More||12/12/2016||TheStreet|
|Analysts' Actions -- Apple, Chipotle, GM, Pandora, Under Armour and More||10/26/2016||TheStreet|
|Earnings Scheduled For October 25, 2016||10/25/2016|
|What TD Ameritrade's IMX Tracker Can Do For Investors, And What It's Been Telling Us||08/14/2016|
|Jim Cramer -- 'The Real Market's Healthier,' So Ignore the Bears||06/13/2016||TheStreet|
|6 Cash-Rich Stocks With Bullish Stock Charts||05/06/2016||TheStreet|
|Earnings Scheduled For April 27, 2016||04/27/2016|
Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.